B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease

Published:2012-02-09 Issue:2 Volume:7 Page:539-547
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Miyake Teruki,Abe Masanori,Tokumoto Yoshio,Hirooka Masashi,Furukawa Shinya,Kumagi Teru,Hamada Maho,Kawasaki Keitarou,Tada Fujimasa,Ueda Teruhisa,Hiasa Yoichi,Matsuura Bunzo,Onji Morikazu

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-012-9345-8.pdf

Reference45 articles.

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–1231

2. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003;18:124–138

3. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917–923

4. Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology 2005;129:375–378

5. Teli MR, James OF, Burt AD, et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714–1719

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis;World Journal of Hepatology;2024-08-27

2. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease;Frontiers in Immunology;2024-08-02

3. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes;Frontiers in Immunology;2024-08-01

4. The PD-1/PD-L1 Axis in the Biology of MASLD;International Journal of Molecular Sciences;2024-03-25

5. Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies;Molecular Aspects of Medicine;2024-02